BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3485203)

  • 1. [The effect of immunochemotherapy with PSK in malignant tumors of the female reproductive organs].
    Fujisawa S; Suzumori K; Yasui Y; Yamamoto T; Yagami Y
    Gan No Rinsho; 1986 Jan; 32(1):65-70. PubMed ID: 3485203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of cimetidine and PSK on interleukin-2 production by PBL in patients with advanced ovarian carcinoma during the course of chemotherapy].
    Kikuchi Y; Kizawa I; Oomori K; Iwano I; Kita T; Miyauchi M; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1987-92. PubMed ID: 3501452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of PSK on interleukin-2 production by peripheral lymphocytes of patients with advanced ovarian carcinoma during chemotherapy.
    Kikuchi Y; Kizawa I; Oomori K; Iwano I; Kita T; Kato K
    Jpn J Cancer Res; 1988 Jan; 79(1):125-30. PubMed ID: 3128500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum].
    Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2241-9. PubMed ID: 2500070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
    Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU.
    Takahashi Y; Mai M; Nakazato H
    Anticancer Res; 2005; 25(2B):1377-84. PubMed ID: 15865094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK.
    Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
    Anticancer Res; 1997; 17(4A):2815-8. PubMed ID: 9252721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapeutic effects of conventional agents and an immunomodulator, PSK, on rat prostatic adenocarcinoma.
    Mickey DD; Carvalho L; Foulkes K
    J Urol; 1989 Dec; 142(6):1594-8. PubMed ID: 2585643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.
    Nakazato H; Koike A; Saji S; Ogawa N; Sakamoto J
    Lancet; 1994 May; 343(8906):1122-6. PubMed ID: 7910230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
    Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
    Dis Colon Rectum; 1992 Feb; 35(2):123-30. PubMed ID: 1735313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
    Ichihashi H; Kondo T; Nakazato H
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
    Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
    Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Compound therapy including PSK for malignant head and neck cancer].
    Hoshiya T; Matsunaga T; Hyo Y; Mori N; Kakiuchi H; Saeki K; Wakuda K
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):91-5. PubMed ID: 7184365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection.
    Kondo T; Sakamoto J; Nakazato H
    Biotherapy; 1991; 3(4):287-95. PubMed ID: 1786194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of PSK on laryngeal cancer].
    Saito H; Hozawa J; Kamata S; Hakamada M; Kasahara M; Takagi A
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1061-7. PubMed ID: 7184440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A randomized controlled study of PSK combined immuno-chemotherapy for adenocarcinoma of the lung. The Advanced Lung Cancer Immuno-chemotherapy Study Group].
    Nishiwaki Y; Furuse K; Fukuoka M; Ota M; Niitani H; Asakawa M; Nakai H; Sakai S; Ogawa N
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):131-6. PubMed ID: 2404455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined modality for recurrent and disseminated ovarian cancer--CAPF combination chemotherapy and second-look operation].
    Inagaki J; Ogawa M; Horikoshi N; Ezaki K; Inoue K; Aiba K; Komyo M; Miyamoto H; Ikeda K; Kubo H
    Gan No Rinsho; 1983 Aug; 29(10):1291-5. PubMed ID: 6685195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor effect of PSK and its combined effect with CDDP on ovarian serous adenocarcinoma-bearing nude mice].
    Ishii K; Kita T; Hirata J; Tode T; Kikuchi Y; Nagata I
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Apr; 45(4):333-9. PubMed ID: 8509669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
    Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
    Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A cooperative study of alternating immunochemotherapy with futraful and PSK (second report)--3-year survival rate].
    Ichihashi H; Kondo T; Yamauchi M; Isomatsu T; Nakamura T; Sakabe T; Nakajima T; Ikenaga T; Shiratori T; Taguchi T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):331-6. PubMed ID: 3918509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.